Literature DB >> 22007761

Evaluation of sustained release of PLC-loaded prednisolone acetate microfilm on postoperative inflammation in an experimental model of glaucoma filtration surgery.

Marcus Ang1, Peng Yan, Ma Zhen, Selin Foo, Subbu S Venkatraman, Tina T Wong.   

Abstract

PURPOSE: To evaluate the effect of a biodegradable microfilm with sustained release of prednisolone acetate (PA) on postoperative wound healing after experimental glaucoma filtration surgery (GFS).
METHODS: Biodegradable microfilms composed of poly (D-, L-lactide-co-caprolactone) (PLC) were fabricated and then pre-loaded PA-20% total weight. Fourteen New Zealand White rabbits were randomly divided into 3 treatment groups: GFS alone (n=4), GFS with PLC microfilms (n=4) and GFS with PA-loaded microfilm (n=6). Microfilms were inserted subconjunctivally, adjacent to the filtering surgical site. We monitored all eyes with slit-lamp examination, bleb photography and anterior segment optical coherence tomography (AS-OCT). Histology with immunohistochemistry was performed to determine the presence of any inflammation.
RESULTS: Prednisolone acetate 20%-loaded microfilms exhibited steady, sustained release in vitro. Eyes implanted with PA-loaded microfilms showed a significantly better bleb survival (100% vs. 37.5%, p<0.001) and reduced bleb vascularity (58%; 95% CI 54-62% vs. 30%; 95% CI 23-37%, p=0.001) compared to the control at 30 days postoperatively. Histology and immunohistochemistry demonstrated less T-cell infiltration in the eye implanted with PA-loaded microfilms.
CONCLUSION: Subconjunctival insertion of a PA-loaded biodegradeable microfilm exhibit sustained release of PA to reduce postoperative inflammation and prolong bleb survival in rabbit GFS.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22007761     DOI: 10.3109/02713683.2011.627489

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  7 in total

Review 1.  Overview of cicatricial modulators in glaucoma fistulizing surgery.

Authors:  Camille Moura de Oliveira; Juliana de Lucena Martins Ferreira
Journal:  Int Ophthalmol       Date:  2020-06-05       Impact factor: 2.031

2.  Paclitaxel-Releasing Thin Biodegradable Film for Prevention of Bleb Avascularity Without Compromising Filtration in Rabbits.

Authors:  Tetsuhiko Okuda; Tomomi Higashide; Mayumi Sakurai; Yukako Fukuhira; Hiroaki Kaneko; Masatsugu Shimomura; Kazuhisa Sugiyama
Journal:  Transl Vis Sci Technol       Date:  2015-06-11       Impact factor: 3.283

3.  Evaluation of a prednisolone acetate-loaded subconjunctival implant for the treatment of recurrent uveitis in a rabbit model.

Authors:  Marcus Ang; Xuwen Ng; Cheewai Wong; Peng Yan; Soon-Phaik Chee; Subbu S Venkatraman; Tina T Wong
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

4.  Evaluation of a Sustained-Release Prednisolone Acetate Biodegradable Subconjunctival Implant in a Non-Human Primate Model.

Authors:  Yu-Chi Liu; Anthony Herr Cheun Ng; Xu Wen Ng; Peng Yan; Subbu S Venkatraman; Jodhbir S Mehta; Tina T Wong
Journal:  Transl Vis Sci Technol       Date:  2017-10-05       Impact factor: 3.283

5.  A biodegradable, sustained-released, prednisolone acetate microfilm drug delivery system effectively prolongs corneal allograft survival in the rat keratoplasty model.

Authors:  Yu-Chi Liu; Yan Peng; Nyein Chan Lwin; Subbu S Venkatraman; Tina T Wong; Jodhbir S Mehta
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

6.  Hypertensive phase and early complications after Ahmed glaucoma valve implantation with intraoperative subtenon triamcinolone acetonide.

Authors:  Angela V Turalba; Louis R Pasquale
Journal:  Clin Ophthalmol       Date:  2014-07-11

Review 7.  Wound Healing Modulation in Glaucoma Filtration Surgery- Conventional Practices and New Perspectives: Antivascular Endothelial Growth Factor and Novel Agents (Part II).

Authors:  Jennifer C Fan Gaskin; Dan Q Nguyen; Ghee Soon Ang; Jeremy O'Connor; Jonathan G Crowston
Journal:  J Curr Glaucoma Pract       Date:  2014-06-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.